Component
Aged-rat brain total iron and copper
Aged-rat brain total iron and copper
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
R-lipoic-acid-containing treatment did not lower total brain iron or copper in the reported old-rat study.
Experimental context and source evidence
- evidence_access
- Primary full text: relevant Results/Methods and figure descriptions reviewed; supplements only where explicitly stated.; Full primary correction read: adds Juvenon financial-interest disclosures, not a changed biochemical result.
- experimental_contrast
- {"intervention": "R-lipoic acid alone or with ALCAR", "comparator": "Untreated aged rats", "endpoint": "R-lipoic-acid-containing treatment did not lower total brain iron or copper in the reported old-rat study.", "effect_direction": "no_detected_change", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Seven-week aged-rat intervention; total-metal measurement.
- interpretation_status
- Source-derived curation with stated access limits; ungraded, not independent replication.
- limitations
- Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
- nutrient_topic
- Acetyl-L-carnitine collection; exact intervention and molecular form govern interpretation. · Acetyl-L-carnitine
- plain_language
- R-lipoic-acid-containing treatment did not lower total brain iron or copper in the reported old-rat study.
- primary_references
- Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid. | https://pubmed.ncbi.nlm.nih.gov/11854488/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC122287/ | https://doi.org/10.1073/pnas.261709098
- primary_references
- Correction | https://pmc.ncbi.nlm.nih.gov/articles/PMC124428/
- source_locator
- Reviewed reference rat-lipoic-metal-null; A null total-metal result is not a measurement of labile-metal pools.
Acetyl-L-carnitine: detailed mechanisms of action (reviewed 6 October 2026) · lines 462–469
AI-assisted original review of primary studies and clearly identified official records. Exact primary access is stated; no independent replication is claimed. · supports · Seven-week aged-rat intervention; total-metal measurement. · Recorded from source · Recorded from source
### rat-lipoic-metal-null R-lipoic-acid-containing treatment did not lower total brain iron or copper in the reported old-rat study. A null total-metal result is not a measurement of labile-metal pools. Model and exposure: Seven-week aged-rat intervention; total-metal measurement. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid. | 2002 | https://pubmed.ncbi.nlm.nih.gov/11854488/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC122287/ | https://doi.org/10.1073/pnas.261709098 | Access: Primary full text: relevant Results/Methods and figure descriptions reviewed; supplements only where explicitly stated. Reference: Correction | 2002 | https://pmc.ncbi.nlm.nih.gov/articles/PMC124428/ | Access: Full primary correction read: adds Juvenon financial-interest disclosures, not a changed biochemical result.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.